Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs

The application of endothelial progenitor cells (EPCs) for the revascularization of ischemic tissues, such as after myocardial infarction, stroke, and acute limb ischemia, has a huge clinical potential. However, the low retention and engraftment of EPCs as well as the poor survival of migrated stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinle, Heidrun, Golombek, Sonia, Behring, Andreas, Schlensak, Christian, Wendel, Hans Peter, Avci-Adali, Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198099/
https://www.ncbi.nlm.nih.gov/pubmed/30343252
http://dx.doi.org/10.1016/j.omtn.2018.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198099/
https://www.ncbi.nlm.nih.gov/pubmed/30343252
http://dx.doi.org/10.1016/j.omtn.2018.09.005

Ejemplares similares